Back to Top Skip to main content

How DHA monitors the spread of health outbreaks

The Armed Forces Health Surveillance Branch (AFHSB) is the central epidemiologic resource for the U.S. Armed Forces, conducting medical surveillance to protect those who serve our nation in uniform and allies who are critical to our national security interests. AFHSB provides timely, relevant, actionable and comprehensive health surveillance information to promote, maintain, and enhance the health of military and military-associated populations. (U.S. Air Force photo by Tech. Sgt. Nathan Lipscomb) The Armed Forces Health Surveillance Branch (AFHSB) is the central epidemiologic resource for the U.S. Armed Forces, conducting medical surveillance to protect those who serve our nation in uniform and allies who are critical to our national security interests. AFHSB provides timely, relevant, actionable and comprehensive health surveillance information to promote, maintain, and enhance the health of military and military-associated populations. (U.S. Air Force photo by Tech. Sgt. Nathan Lipscomb)

Recommended Content:

Combat Support | Public Health | Coronavirus | Coronavirus

The Defense Health Agency works as a combat support agency to the military services and Military Health System with epidemiology data that improves the health and readiness of all service members and their beneficiaries.

Here’s how the Armed Forces Health Surveillance Branch is supporting the coronavirus (COVID-19) outbreak.

How We Monitor

COVID-19 is a reportable medical event (RME) in the military. RMEs are medical conditions, such as measles, which when found in individuals, potentially impact larger groups of people. The tri-service reporting system for RMEs is the Disease Reporting System internet (DRSi). The Alert and Response Ops group within the Integrated Biosurveillance section of the AFHSB at DHA tracks and reports information about COVID-19 from DRSi daily.

AFHSB also conducts daily surveillance using the Electronic Surveillance System for the Early Notification of Community-based Epidemics (ESSENCE). The ESSENCE team developed a dashboard that monitors information from the electronic medical record to detect clinical activity suspicious or diagnostic of COVID-19 in beneficiary populations at all military treatment facilities. It also alerts public health professionals about potential disease outbreaks and epidemics so appropriate countermeasures can be taken.

“The COVID-19 time-series graphs from ESSENCE are shared by combatant commands through the Joint Staff,” said Juan Ubiera, Chief, Integrated Biosurveillance. “AFHSB has also created a mailbox for questions related to the COVID-19 dashboard.”

The division’s Epidemiology and Analysis (E&A) section uses the Defense Medical Surveillance System to analyze medical encounter and other health care data, including data from outsourced care, to track disease trends. This allows E&A to produce regular reports, such as the weekly DoD Consolidated Influenza Surveillance Report.

“We are reviewing guidance from the U.S. Centers for Disease Control and Prevention and the World Health Organization to determine the feasibility and value of producing a weekly COVID-19 report that will add to the reports produced by the Integrated Biosurveillance team in the unlikely event that COVID-19 becomes widespread,” said Navy Cmdr. (Dr.) Shawn Clausen, AFHSB’s Epidemiology and Analysis Chief.

COVID-19 Lab Testing Kits

AFHSB Global Emerging Infections Surveillance (GEIS) section is coordinating efforts with DoD and interagency partners to ensure DoD network labs can globally support detection and characterization of COVID-19 cases. GEIS currently funds ongoing surveillance efforts of animal markets on the Vietnam-China border and provides laboratory support for detection of respiratory diseases throughout a global network.

GEIS has supported COVID-19 activities through coordination of guidance as well as reagent procurement and distribution of surveillance testing material across the Military Health System network.

As of March 5, the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) had received and performed validation of surveillance reagents and observed no issues with performance.

Additionally, the reagents have been shipped to GEIS-supported laboratories including Naval Medical Research Units (NAMRU) in the Middle East, Southeast Asia, and South America; Armed Forces Research Institute of Medical Sciences (AFRIMS); U.S. Army Medical Research Directorate-Africa (including associated test sites in Uganda and Tanzania); USMRD – Georgia; Landstuhl Regional Medical Center (LRMC), U.S. Naval Health Research Center; and U.S. Air Force School of Aerospace Medicine. Currently, all GEIS-supported laboratories, with the exception of NAMRU-3 sites in Egypt and Jordan, have received the test kits and are ready to provide surveillance support as requested.

These tests are molecular-based, COVID-19 detection assays that enable sample analysis and results in 4-6 hours. In addition, optimized Next-Generation Sequencing (NGS) assays are evaluated by the GEIS NGS consortium partners and shared with partner laboratories when available. Through this support, GEIS-funded laboratories in Southeast Asia and across the network continue to provide information and analytical laboratory support to the geographic combatant commands and countries in their region.

“Testing kits specifically procured through U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) are intended for surveillance use in DoD laboratories. The primers and probes, and protocols, for the USAMRIID testing kits are the same as the CDC Emergency Use Authorization assay; however, DoD labs are only to use the testing kits for nonclinical/surveillance testing,” said Navy Cmdr. (Dr.) Mark Scheckelhoff, who leads the Respiratory Infections focus area for AFHSB's Global Emerging Infections Surveillance section.

International Health Surveillance 

Along with research, AFHSB concluded a NATO health surveillance collaboration meeting with international force health protection leaders March 11 at AFHSB headquarters in Silver Spring, Maryland.

“We recognize that there is a lack of robust information sharing for military partners in NATO,” said O. Sean Friendly, AFHSB’s chief of operations and administration. “Through this ‘Smart Defense’ process, we are trying to close that gap with a shared health surveillance.”

The purpose of the two-part meetings was to develop a concept for a shared international mapping capability, similar to that of DoD’s Health Surveillance Explorer.

“If this capability were already in place, we would be able to see how this recent health outbreak of COVID-19 is impacting the movement of military troops in our NATO partnership,” said Friendly. “An international map would allow us to see how public health outbreaks impact the movement, mission, and ability of our troops to be healthy.”

 

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy

U.S. Navy/U.S. Marine Corps COSC Policy Update

Policy

Mental Health Assessments for Members of the Armed Forces Deployed in Connection with a Contingency Operation

Policy

Clinical Policy for the Administration of the Anthrax Vaccine Adsorbed

Policy

DoD Directive 6490.5 on Combat Stress Control Programs

Policy
Showing results 1 - 11 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.